Top

Published in:

01-09-2014 | Letter to the editor

Making quality of life assessment a dashboard for patient management

Authors: Andrea Tendas, Pasquale Niscola, Laura Scaramucci, Marco Giovannini, Teresa Dentamaro, Alessio Pio Perrotti, Paolo de Fabritiis

Published in: Supportive Care in Cancer | Issue 9/2014

Excerpt

To the Editor, …

Denis F, Viger L, Charron A, Voog E, Letellier C (2014) Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up. Support Care Cancer 22(1):79–85PubMedCrossRef

Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A (1998) How well do medical oncologists’ perceptions reflect their patients’ reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 83(8):1640–1651PubMedCrossRef

Liau CT, Chu NM, Liu HE, Deuson R, Lien J, Chen JS (2005) Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians’ and nurses’ estimation vs. patients’ reported outcomes. Support Care Cancer 13(5):277–286PubMedCrossRef

Efficace F, Bottomley A, Smit EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smit HJ, Gaafar R, Biesma B, Manegold C, Coens C, Giaccone G, Van Meerbeeck J (2006) EORTC Lung Cancer Group and Quality of Life Unit. Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 17(11):1698–1704PubMedCrossRef

Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Schöffski P, Schmoll H, Van Cutsem E, Köhne CH (2006) Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 42(1):42–49, Epub 2005 Nov 18. Erratum in: Eur J Cancer. 2007 Feb;43(3):633PubMedCrossRef

Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, Bottomley A (2004) Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 22(16):3381–3388PubMedCrossRef

Efficace F, Cartoni C, Niscola P, Tendas A, Meloni E, Scaramucci L, Soldati S, Brunetti GA, Marini MG, Mandelli F (2012) Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter? Eur J Haematol 89(5):410–416. doi:10.1111/ejh.12004 PubMedCrossRef

Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M (2012) Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res 21(8):1305–1314PubMedCrossRef

Guihot A, Becquemin MH, Couderc LJ, Randrianarivelo O, Rivaud E, Philippe B, Sutton L, Neveu H, Tanguy ML, Vernant JP, Dhédin N (2007) Telemetric monitoring of pulmonary function after allogeneic hematopoietic stem cell transplantation. Transplantation 83(5):554–560PubMedCrossRef

10.

Tendas A, Pignatelli AC, Sollazzo F, Veggia B, Conte E, D'Apolito A, Di Veroli A, Molinari V, Mauroni M, Annibali O, Pilozzi V, Cacciaraichi S, Viggiani C, Niscola P, de Fabritiis P, Arcese W, Rome Transplant Network (2013) Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the Rome Transplant Network Quality of Life Working Party. J Pain Symptom Manag 45(4):e2–e3CrossRef

Title: Making quality of life assessment a dashboard for patient management
Authors: Andrea Tendas
Pasquale Niscola
Laura Scaramucci
Marco Giovannini
Teresa Dentamaro
Alessio Pio Perrotti
Paolo de Fabritiis
Publication date: 01-09-2014
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 9/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-014-2342-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2014

Referral practices of pediatric oncologists to specialized palliative care

An investigation of the colorectal cancer experience and receptivity to family-based cancer prevention programs

Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial

Does a regional comprehensive palliative care program improve pain in outpatient cancer patients?

Caregivers as healthcare managers: health management activities, needs, and caregiving relationships for colorectal cancer survivors with ostomies

Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer